NIH-funded research NIH-funded research

Community-based Biomedical HIV Research Facility to accelerate next-generation AIDS science

Official title: Developing a Community-Based Facility to Support Next Generation Biomedical HIV Research

Funded at Whitman-Walker Institute, INC. · NIH-11581448 · Data updated 2026-11-12

A community-focused center in Washington, DC will expand facilities and services to support HIV research, from patient care and specimen handling to trials and translation of findings.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWhitman-Walker Institute, INC.
NIH-funded
Lab location1 site (Washington, United States)
Project startSeptember 18, 2026
Project endMay 31, 2027
Funding year2026
Award (this year)$499,000
NIH project number3C06OD034040-01S2
Project IDNIH-11581448 on NIH RePORTER

Who could benefit from this research

Could help

Individuals living with HIV or at risk for HIV who may benefit from improved access to research opportunities and advanced diagnostic services within a community setting.

Less likely to help

People without HIV or those not involved in research activities at this hub may not directly benefit from these specialized services.

What this research studies

This grant funds a new Biomedical Research Hub at a trusted healthcare organization to boost HIV-related science in the community. It integrates clinical diagnostics, biospecimen handling, and investigational pharmacy with implementation science and clinical research to support a full continuum of HIV studies. The center will enable investigator-initiated studies, federally funded trials, translational work, and community-led research, all aiming to bring advances to people affected by HIV. Researchers, clinicians, and patients will work together to improve access to cutting-edge HIV care and science. The project emphasizes infrastructure that can adapt to evolving HIV research needs while engaging communities most affected by the disease.

Why it matters

Potential benefit: If successful, this hub could speed the development of new HIV treatments and diagnostics while making advanced research more accessible to people in the community.

How similar studies have gone: Similar community-based HIV research infrastructures have shown promise in expanding access to trials and improving translational outcomes.

Where this research is happening

  • Whitman-Walker Institute, INC.
    Washington, United States
    Active

Researchers

  • Principal investigator: Aaron, Heather Julie — Whitman-Walker Institute, INC.
  • Study coordinator: Aaron, Heather Julie

Related research

Other NIH-funded projects on the same topics.

  • Community-based biomedical HIV research hub enhances care and science

    A community-focused research facility in Washington, DC will expand HIV clinical care, specimen handling, and trial work to bring advanced science and new treatments closer to people affected by HIV.

    NIH research Whitman-Walker Institute, INC. · Washington, United States · NIH-11581447

  • Exploring how to help newly diagnosed HIV-positive men maintain low viral loads.

    This study is looking at the challenges that gay and bisexual men in the U.S. face after being newly diagnosed with HIV, to help find better ways to support them in keeping their viral load low and preventing the spread of the virus.

    NIH research Whitman-Walker Institute, INC. · Washington, United States · NIH-11046508

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.